Fresenius Medical Care Receives FDA Clearance for Updated 5008X CAREsystem, Expanding High-Volume Hemodiafiltration in U.S.

Fresenius Medical Care Receives FDA Clearance for Updated 5008X CAREsystem, Expanding High-Volume Hemodiafiltration in U.S.

Fresenius Medical Care Receives FDA Clearance for Updated 5008X CAREsystem, Expanding High-Volume Hemodiafiltration in U.S. (IN BRIEF) Fresenius Medical Care has received FDA 510(k) clearance for its updated 5008X CAREsystem with additional features, enabling the introduction of high-volume hemodiafiltration therapy across the U.S. This new therapy, proven to reduce mortality rates by 23% in patients, will be rolled out in selected Fresenius Kid…

Fresenius Medical starts US commercialisation of haemodiafiltration system

Fresenius Medical Care (FME) has commenced the US commercialisation of its high-volume haemodiafiltration (HVHDF) kidney replacement therapy, 5008X CAREsystem.The post Fresenius Medical starts US commercialisation of haemodiafiltration system appeared first on Medical Device Network.